MicroPort CardioFlow Medtech Past Earnings Performance
Past criteria checks 0/6
MicroPort CardioFlow Medtech's earnings have been declining at an average annual rate of -15.7%, while the Medical Equipment industry saw earnings growing at 14.7% annually. Revenues have been growing at an average rate of 27.3% per year.
Key information
-15.7%
Earnings growth rate
-8.3%
EPS growth rate
| Medical Equipment Industry Growth | 13.7% |
| Revenue growth rate | 27.3% |
| Return on equity | -15.9% |
| Net Margin | -91.0% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
MicroPort CardioFlow Medtech Corporation (HKG:2160) Stocks Shoot Up 34% But Its P/S Still Looks Reasonable
Sep 27
After Leaping 34% MicroPort CardioFlow Medtech Corporation (HKG:2160) Shares Are Not Flying Under The Radar
Sep 27Are Investors Undervaluing MicroPort CardioFlow Medtech Corporation (HKG:2160) By 43%?
Aug 07Some MicroPort CardioFlow Medtech Corporation (HKG:2160) Shareholders Look For Exit As Shares Take 26% Pounding
Jun 19MicroPort CardioFlow Medtech (HKG:2160) Is In A Good Position To Deliver On Growth Plans
May 29MicroPort CardioFlow Medtech Corporation (HKG:2160) Shares May Have Slumped 29% But Getting In Cheap Is Still Unlikely
Apr 05We Think MicroPort CardioFlow Medtech (HKG:2160) Can Afford To Drive Business Growth
Feb 23An Intrinsic Calculation For MicroPort CardioFlow Medtech Corporation (HKG:2160) Suggests It's 37% Undervalued
Jan 18Companies Like MicroPort CardioFlow Medtech (HKG:2160) Are In A Position To Invest In Growth
Oct 04Not Many Are Piling Into MicroPort CardioFlow Medtech Corporation (HKG:2160) Stock Yet As It Plummets 27%
May 31We Think MicroPort CardioFlow Medtech (HKG:2160) Can Afford To Drive Business Growth
May 23The MicroPort CardioFlow Medtech Corporation (HKG:2160) Analysts Have Been Trimming Their Sales Forecasts
Apr 06MicroPort CardioFlow Medtech (HKG:2160) Is In A Good Position To Deliver On Growth Plans
Feb 08We Think MicroPort CardioFlow Medtech (HKG:2160) Can Afford To Drive Business Growth
Oct 18We're Not Very Worried About MicroPort CardioFlow Medtech's (HKG:2160) Cash Burn Rate
Jun 30Analysts Just Made A Major Revision To Their MicroPort CardioFlow Medtech Corporation (HKG:2160) Revenue Forecasts
Apr 04MicroPort CardioFlow Medtech Corporation (HKG:2160) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Apr 03An Intrinsic Calculation For MicroPort CardioFlow Medtech Corporation (HKG:2160) Suggests It's 49% Undervalued
Jan 21Are Investors Undervaluing MicroPort CardioFlow Medtech Corporation (HKG:2160) By 24%?
Sep 05We're Not Worried About MicroPort CardioFlow Medtech's (HKG:2160) Cash Burn
Jun 07Market Sentiment Around Loss-Making MicroPort CardioFlow Medtech Corporation (HKG:2160)
May 03Revenue & Expenses Breakdown
How MicroPort CardioFlow Medtech makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 383 | -349 | 297 | 211 |
| 31 Mar 24 | 360 | -410 | 295 | 224 |
| 31 Dec 23 | 336 | -472 | 293 | 237 |
| 30 Sep 23 | 319 | -491 | 273 | 246 |
| 30 Jun 23 | 303 | -511 | 253 | 254 |
| 31 Mar 23 | 277 | -483 | 243 | 239 |
| 31 Dec 22 | 251 | -454 | 233 | 224 |
| 30 Sep 22 | 245 | -345 | 213 | 203 |
| 30 Jun 22 | 239 | -236 | 193 | 182 |
| 31 Mar 22 | 220 | -209 | 173 | 166 |
| 31 Dec 21 | 201 | -183 | 152 | 151 |
| 30 Sep 21 | 176 | -265 | 131 | 133 |
| 30 Jun 21 | 151 | -346 | 111 | 116 |
| 31 Mar 21 | 128 | -372 | 104 | 106 |
| 31 Dec 20 | 104 | -398 | 97 | 97 |
| 31 Dec 19 | 22 | -145 | 37 | 97 |
Quality Earnings: 2160 is currently unprofitable.
Growing Profit Margin: 2160 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 2160 is unprofitable, and losses have increased over the past 5 years at a rate of 15.7% per year.
Accelerating Growth: Unable to compare 2160's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 2160 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-4.3%).
Return on Equity
High ROE: 2160 has a negative Return on Equity (-15.92%), as it is currently unprofitable.